Allakos Investigational Site 216-020 — Chapel Hill, North Carolina

Allakos Investigational Site 216-020 is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Allakos Investigational Site 216-020 has participated in 1 clinical trials.

Therapeutic areas: Eosinophilic Gastritis, Eosinophilic Duodenitis.

Sponsors: Allakos Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Allakos Investigational Site 216-020?

Allakos Investigational Site 216-020 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Allakos Investigational Site 216-020 conducted?

Allakos Investigational Site 216-020 has 1 clinical trials on record. Their work covers Eosinophilic Gastritis, Eosinophilic Duodenitis.

Is Allakos Investigational Site 216-020 accredited by Crixeo Health?

Allakos Investigational Site 216-020 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Allakos Investigational Site 216-020?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.